2008, Number 5
Consumo de drogas en mujeres asistentes a centros de tratamiento especializado en la Ciudad de México
Castillo Franco PI, Gutiérrez LAD
Full text
Language: Spanish
References: 27
Page: 351-359
PDF size: 136.29 Kb.
ABSTRACT
Introduction: There is plenty information about drug consumption in Mexico which examines from an epidemiological perspective several social groups such as: general population, student population, treatment centers, non-governmental organisms, homeless children, social re-adaption centers and even rural areas. However, these studies report drug consumption by gender and do not allow a precise analysis about specific characteristics in women, as the proportions of drug use are divergent and in some cases extremely different from those shown by men.This study analyses, specifically, women that received treatment according to age when admitted to a specialized institution, since it has been shown that age can influence drug use as well as treatment required. Also, it allows the introduction of prevention and treatment programs specifically for women.
Methodology: The objective of this study is to determine if there are significant differences in certain socio-demographic characteristics as weel as in factors related to the demand of drug treatment and consumption, according to female drug users age when admitted to treatment in CIJ.
The study was based on information from the System of Epidemiological Information on Drug Consumption of CIJ. The design was exploratory, transversal and with a bi-varied analysis. The sample was non probabilistic and intentional, consisting of 754 drug users that arrived for the first time to CIJ between July and December 2004 in Mexico City.
Furthermore, the sample was divided into three groups, according to admission age, as follows: Group 1. Women between 12 and 20 years old (n=242); group 2. Women between 21 and 39 years old (n=277), and group 3. Women 40 years old and older (n=231).
Results: The sample showed a 31 years old average (DE=14.8) upon being admitted to CIJ: 51.2% were single, 32.6% were married or lived in cohabitation, 30.1% have studied high school; 32.8% stated that they had remunerated employment, 25.4% were homemakers and 23.8% were students. On average tobacco consumption starting age was 16.5 years old (DE=5.3), alcoholic drinks 17 years old (DE=5.9) and illegal drugs 18.5 years old (DE=9.2).
Tobacco (71.6%) was the main substance with which these women started drug use, followed by alcoholic drinks (19.9%). The most frecuently used illegal drugs as «first» substances were: marijuana (43.5%), solvents/removers (14.8%) and cocaine hydrochloride (11.8%).
The most frecuently consumed drugs once in a lifetime were: tobacco (89.3%), alcoholic drinks (77.3%), marijuana (30.4%), crack (18.4%), cocaine hydrochloride (17.0%) and solvents and removers (15.4%). During the last year of use they were: tobacco (82.9%), alcoholic drinks (65.6%), marijuana (19.4%), crack (15.3%), cocaine hydrochloride (10.9%) and solvents and removers (10.1%). During the last month of use they were: tobacco (77.2%), alcoholic drinks (47.3%), marijuana (10.7%), crack (9.5%). In these three stages they consumed on average, including tobacco and alcoholic drinks, 2.9, 2.3 and 1.7 drugs respectively.
Additionally, the sample shows that drugs prefered by women as well as those drugs that were harmful and damaging to their family, work or social life in the last year of use were: tobacco (48.9% vs 46.0%), alcohol drinks (20.0%) and crack (10.1% vs 10.7%).
Furthermore, when comparing age groups it was observed that there were differences (p≤0.05) regarding marital status, education and occupation; finding, as could be expected according to the cycle of life, a larger proportion of women without partners in group 1 and 2; while the larger proportion of women that have at least 10 years of education (high school or more) were found in groups 2 and 3.
The larger number of employed and unemployed women were found in group 1 while the largest percentage of homemakers were found in group 3.
Likewise relevant differences were found (p≤0.05)regarding the following events: seeking treatment for tobacco use, alcohol and/or illegal drugs; seeking treatment by own initiative or conditioned by their family or due to medical guidance; interrupting consumption voluntarily without support and participating in self help groups; and current health, family, work, as well as psychological problems caused by drug consumption.
The larger cases that were admitted because of illegal drugs or alcohol consumption were found in group 1, followed by group 2; while those admitted due to tobacco consumption were found in group 3. In the group 3, there was largest percentage of women seeking profesional help by their own will or following medical guidance, while those attending conditioned by their family were found in group 1.
Additionally the largest proportion of women who attended support groups or that interrupted drug consumption at one time or another without support were found in group 2.
The highest percentage of family problems associated to drug consumption was found in group 1; while health problems were found in group 3 and psychological or labor problems in group 2.
Regarding drug consumption there were some relevant differences (p≤0.05) in the categories of «first used» drugs, such as: drugs consumed once in a lifetime, consumption in the last year, consumption in the last month, drug of preference during the last year, drug of greatest impact during the last year of consumption and consumption of two or more substances in the same day during the last year.
According to once in a lifetime consumption, there were relevant differences (p≤0.05) between groups mainly in the use of: tobacco, alcoholic drinks, marijuana, cocaine, depressors and stimulants. However, between group 1 and 2 there were also differences (p≤0.05) in the consumption of inhalants.
In the last year and in the last month at consumption, all groups differ from each other (p≤0.05) in tobacco and alcohol use. Also, in the last year of consumption differences were observed in the use of depressors.
Also, when comparing groups 1 and 2 (p≤0.05) there were also found relevant differences in tobacco, marijuana, cocaine and inhalants consumption during the last year and the last months of consumption.
Regarding consumption of alcoholic drinks, marijuana and inhalants once in a lifetime -in the last year and in the last month of consumption-, the highest proportion was found in group 1, as that found in cocaine in group 2 and that of tobacco in group 3.
Even though tobacco, alcoholic drinks and illegal drugs were drugs of preference and of greatest impact during the last year of consumption, they showed different proportions between groups as follows (p≤0.5): group one reported the highest percentage of illegal drugs and alcohol while in group three the higher percentage was found in tobacco; and in group 2 tobacco and illegal drugs also yielded high percentages.
Lastly, most cases where two or more drugs were consumed in the same day during the last year of consumption were found in group one, differing (p≤0.05) to those of group 2.
Discussion: Consequently it is very important to study drug users taking into account characteristics that allow us to provide information about their specific needs.
This study offers evidence of relevant differences between women who seeked treatment at CIJ as well as differences related to age when admitted for treatment and that contributes useful elements to make progress in the development of differentiated preventative care and treatment for women in specialized institutes.
Despite their limits, the results obtained offer a useful parameter for developing health care alternatives that will take into account factors such as drug users age, family, as well as social and health problems, substances that they have used in the past and those that they are consuming.
As a result, this study will allow us to improve specific treatments for each drug user that decides to seek specialized treatment; as well as to save human and economic resources. Taking the group of 40 years and older into consideration, the need for care programs focused on the use of tobacco becomes evident. In addition, in the group of women between 21 and 39 years old the programs could consider diverse treatments and even combine them where the consumption of tobacco and illegal drugs, as well as the organic and psychological damage caused by these is taken into account. In the group of women under 21 years old, the necessity to apply multiple treatments that take into consideration the consumption of alcohol and illegal drugs, as well as developing strategies that involve both families and schools, is detected.
The findings coincide with those presented by the United Nations Office on Drugs and Crime, indicating that international policy should propose the application of specific treatment with women who consume illegal substances and that the reduction programs of drug consumption and demand should be conceived in such a way that they respond both to the needs of the general population and also to determined groups of the population.
REFERENCES
Díaz D, Balanzario M, Castillo I, Gutiérrez A, García R. Servicios de atención especializada. Uso de drogas entre pacientes de primer ingreso a tratamiento en Centros de Integración Juvenil. Observatorio Epidemiológico en Drogas 2001. El fenómeno de las adicciones en México. México: Secretaria de Salud; 2001; p. 66-71.
Guisa V, Sánchez R, Díaz D, Castillo I, Gutiérrez A, Gracia S. Consumo de drogas en pacientes de primer ingreso a tratamiento en Centros de Integración Juvenil en 2002. Observatorio Mexicano en Tabaco, Alcohol y otras Drogas 2003. México: Secretaría de Salud, Consejo Nacional contra las Adicciones; 2004; p. 33-43.
Instituto Nacional de Estadística Geografía e Informática, Organización de las Naciones Unidas para la Atención a la Infancia, Organización de las Naciones Unidas para la Atención a la Mujer, Organización Panamericana de la Salud/Organización Mundial de la Salud. Serie estadísticas de género. El enfoque de género en la producción de estadísticas de salud en México una guía para el uso y una referencia para la producción de información. VIII Adicciones; México: 2001; p. 69-72.
Romero MP, Rodríguez E, Saldivar GJ. La reducción del daño por el abuso de drogas en mujeres. En: Romero MP (coord.) Mujeres en prisión: una mirada a la salud mental. México: Instituto Nacional de Capacitación Penitenciaria, Gobierno del Distrito Federal, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz; 2004; p. 155-175.